HF
GILD icon

Hoxton Financial’s Gilead Sciences GILD Stock Holding History

Hoxton Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$18K Hold
200
– – 0.01% 216
2015
Q4 		$20K Hold
200
– – 0.01% 195
2015
Q3 		$20K Buy
+200
New +$22.2K 0.01% 184
2014
Q4 		– Sell
-100
Closed -$11K – 355
2014
Q3 		$11K Hold
100
– – ﹤0.01% 208
2014
Q2 		$8K Hold
100
– – ﹤0.01% 223
2014
Q1 		$7K Sell
100
-918
-90% -$72K ﹤0.01% 236
2013
Q4 		$76K Buy
+1,018
New +$70.9K 0.03% 182

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hoxton Financial's GILD Position: Q1 2016 in Review

Hoxton Financial held its Gilead Sciences (GILD) position steady in Q1 2016 at 200 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #216.

Hoxton Financial first reported a position in GILD in Q4 2013 and has held it in 7 quarters since. The position peaked at $76K in Q4 2013. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Hoxton Financial held 200 shares of Gilead Sciences worth $18K as of Q1 2016.
  • Hoxton Financial left its Gilead Sciences share count unchanged in Q1 2016.
  • Gilead Sciences made up 0.01% of Hoxton Financial's portfolio in Q1 2016, its #216 holding.
  • Hoxton Financial first reported a position in Gilead Sciences in Q4 2013 and has held it in 7 quarters since.
  • Hoxton Financial's Gilead Sciences position peaked at $76K in Q4 2013.
  • 1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.